Granulocyte alkaline phosphatase activity: a measure of the emergence time of mature marrow neutrophils?
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced / Q000150:complications / Q000201:enzymology; D000469:Alkaline Phosphatase / Q000097:blood*; D001853:Bone Marrow / Q000201:enzymology*; D001854:Bone Marrow Cells; D001856:Bone Marrow Examination; D001966:Bromine / Q000009:adverse effects; D002271:Carbutamide / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D005260:Female; D006394:Hemangiosarcoma / Q000188:drug therapy; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced / Q000201:enzymology; D008297:Male; D008353:Mannitol / Q000009:adverse effects; D008875:Middle Aged; D009504:Neutrophils / Q000201:enzymology*; D018805:Sepsis / Q000209:etiology; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D008353:Mannitol; D014750:Vincristine; D003520:Cyclophosphamide; D002271:Carbutamide; D000469:Alkaline Phosphatase; D001966:Bromine